Target: BRAF V600

Ivette Giancola tells CBS News that when she learned she had stage four pancreatic cancer, she wasn't sure she was going to make it.

"You hear the word 'metastasized' and it's very, very scary," she says.

However, CBS News says that Giancola was eligible to take part in a personalized medicine study using a therapeutic targeted to a genetic mutation found in her tumor.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Microsoft co-founder Paul Allen also contributed to brain research, NPR reports.

The New York Times reports on the shifting interpretations of what some genetic variants mean over time.

MIT's Technology Review reports on Genentech's pursuit of personalized cancer vaccines.

In Cell this week: investigation of metastatic tumor evolution, more than 16,000 genetic variants introduced into the budding yeast model organism, and more.